International Biotechnology Trust (LSE:IBT) Total Stockholders Equity : £286.51 Mil (As of Feb. 2024)

View and export this data going back to 1994. Start your Free Trial

What is International Biotechnology Trust Total Stockholders Equity?

International Biotechnology Trust's Total Stockholders Equity for the quarter that ended in Feb. 2024 was £286.51 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. International Biotechnology Trust's Book Value per Share for the quarter that ended in Feb. 2024 was £7.49. The ratio of a company's debt over equity can be used to measure how leveraged this company is. International Biotechnology Trust's Debt-to-Equity for the quarter that ended in Feb. 2024 was 0.10.

International Biotechnology Trust Total Stockholders Equity Historical Data

The historical data trend for International Biotechnology Trust's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

International Biotechnology Trust Total Stockholders Equity Chart

International Biotechnology Trust Annual Data

Trend

Aug14

Aug15

Aug16

Aug17

Aug18

Aug19

Aug20

Aug21

Aug22

Aug23

Total Stockholders Equity

Get a 7-Day Free Trial

239.58

283.90

323.78

284.89

270.32

International Biotechnology Trust Semi-Annual Data
	Aug14	Feb15	Aug15	Feb16	Aug16	Feb17	Aug17	Feb18	Aug18	Feb19	Aug19	Feb20	Aug20	Feb21	Aug21	Feb22	Aug22	Feb23	Aug23	Feb24
Total Stockholders Equity	Get a 7-Day Free Trial															267.04	284.89	295.50	270.32	286.51

International Biotechnology Trust (LSE:IBT) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

International Biotechnology Trust's Book Value per Share for the quarter that ended in Feb. 2024 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(286.509	-	0)	/	38.2574
	=	7.49

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

International Biotechnology Trust's Debt-to-Equity for the quarter that ended in Feb. 2024 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0	+	27.669)	/	286.509
	=	0.10

International Biotechnology Trust Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of International Biotechnology Trust's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

International Biotechnology Trust Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » International Biotechnology Trust PLC (LSE:IBT) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

IBTl:UK

Address

65 Gresham Street, 6th Floor, London, GBR, EC2V 7NQ

Website

https://www.ibtplc.com

International Biotechnology Trust PLC is an investment trust company. It aims at achieving long-term capital growth by investing in biotechnology and other life sciences companies. It seeks to achieve its objective by investing in a diversified portfolio of companies which has good growth prospects. It focuses on investments in biotechnology companies which are engaged in on drug discovery and development, medical devices companies and healthcare services provider. The invests in various financial instruments such as equities, index-linked securities, debt securities, cash deposits, money market instruments and foreign currency exchange transactions. Its revenue comprises of dividend, interest and other income from investment made.

International Biotechnology Trust Headlines

No Headlines